glaucoma | WRAL TechWire


Durham-based Aerie Pharma receives FDA approval for glaucoma treatment

RESEARCH TRIANGLE PARK – Durham-based Aerie Pharmaceuticals, a developer of therapies for eye diseases, has received approval from the U.S. Food and Drug Administration (FDA) to begin selling Rocklatan, a once-daily eye drop for reducing high intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Rocklatan is a combination of latanoprost,...

Read More